Antidepressant alleviates depression in peri – and postmenopausal women: Study An antidepressant can alleviate symptoms of main depression in women experiencing or about to see menopause, according to a study released today led by a Virginia Commonwealth University researcher. The extensive study compared the efficiency and security of the antidepressant desvenlafaxine, referred to as Pristiq, to a placebo in a double-blind trial led by Susan G. Kornstein, M .D., a professor of psychiatry and obstetrics/gynecology in the VCU School of Medication. It was published in the Journal of Clinical Psychiatry.


Increased levels of C-reactive protein in particular are connected with improved risk for the advancement or progression of several illnesses including heart disease, and stroke. ‘This evaluation provides the most compelling evidence to date that variations in antipsychotic metabolic liability are also seen with markers of systemic inflammation,’ explained Dr. Meyer. ‘In addition, it provides an impetus for monitoring cardiovascular risk markers in antipsychotic treated sufferers.’ Dr. John Krystal, the Editor of Biological Psychiatry, which is certainly publishing this record, commented, ‘Doctors always make an effort to balance the benefits and the dangers connected with medicines when making the decision to prescribe a specific medication to a particular patient.